Fitoterapijos centras, MB - financials and debts

Company age: 34 y. 2 mo.

Update

Fitoterapijos centras - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 86,227 98,177 104,313 88,209 90,663 92,821 80,632 72,076
Profit before tax 37,702 46,017 49,268 33,188 34,958 36,323 23,918 19,238
Net profit 39,563 43,716 46,805 31,428 33,210 34,507 22,722 18,083
Equity 161,909 193,023 226,422 243,224 261,546 281,515 287,806 169,663
Liabilities - - - - 3,817 3,963 4,494 2,272
Non-current assets 10,412 7,880 5,507 4,200 1,867 842 418 190
Current assets 154,039 190,376 226,885 239,691 263,496 284,636 291,882 171,745
Total assets 164,451 198,256 232,392 243,891 265,363 285,478 292,300 171,935
Taxes paid
STI taxes - - - - - 20,681 17,534 16,024
Financial indicators
Revenue change y/y -3.7% +13.9% +6.2% -15.4% +2.8% +2.4% -13.1% -10.6%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 24.1% 22.1% 20.1% 12.9% 12.5% 12.1% 7.8% 10.5%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 24.4% 22.6% 20.7% 12.9% 12.7% 12.3% 7.9% 10.7%
Profit margin Net profit margin. Shows the overall profitability of the company. 45.9% 44.5% 44.9% 35.6% 36.6% 37.2% 28.2% 25.1%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 43.7% 46.9% 47.2% 37.6% 38.6% 39.1% 29.7% 26.7%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. - - - - 0.0 0.0 0.0 0.0
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. - - - - - - - -

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Fitoterapijos centras - Social security debts

The company had no debts to Sodra

Fitoterapijos centras - VMI tax arrears

As of 2026-09-02, the amount of overdue STI tax debt of the company Fitoterapijos centras is: 1 €

From To Overdue, €
2026-08-28 2026-09-02 1.2
2026-08-25 2026-08-25 1.2
2026-07-30 2026-08-24 0.6
2026-07-21 2026-07-26 0.6
2026-06-01 2026-06-05 1.2
2026-05-31 2026-05-31 0.9
2026-05-28 2026-05-30 0.6
2026-05-01 2026-05-25 0.6
2026-04-30 2026-04-30 0.3
2026-03-22 2026-03-22 2.56
2026-03-16 2026-03-21 1.6
2026-03-13 2026-03-15 64.0
2026-03-02 2026-03-12 1.6
2026-02-21 2026-02-21 1.0
2026-02-03 2026-02-16 3.44
2026-01-31 2026-02-02 3.14
2026-01-29 2026-01-30 2.82
2026-01-01 2026-01-24 2.82
2025-12-22 2025-12-29 2.82
2025-12-01 2025-12-21 2.26
2025-11-28 2025-11-30 1.66
2025-10-21 2025-11-25 1.66
2025-10-02 2025-10-20 1.1
2025-09-30 2025-10-01 0.86
2025-09-28 2025-09-29 0.6
2025-09-14 2025-09-25 0.6
2025-09-01 2025-09-12 0.6
2025-08-31 2025-08-31 0.32
2025-06-28 2025-07-21 1.12
2025-06-19 2025-06-25 0.58
2025-06-02 2025-06-14 0.58
2025-05-31 2025-06-01 0.3
2025-04-28 2025-05-01 0.56
2025-04-22 2025-04-25 0.56
2025-04-02 2025-04-02 0.48
2025-03-31 2025-04-01 0.2
2025-02-27 2025-03-01 0.63
2025-02-20 2025-02-24 3.5
2025-02-02 2025-02-16 3.5
2025-01-31 2025-02-01 3.2
2025-01-30 2025-01-30 2.9
2025-01-28 2025-01-29 0.56
2025-01-01 2025-01-27 2.9
2024-12-31 2024-12-31 2.64
2024-12-30 2024-12-30 2.34
2024-12-15 2024-12-27 2.34
2024-12-14 2024-12-14 1.72
2024-12-03 2024-12-13 2.34
2024-12-01 2024-12-02 2.04
2024-11-28 2024-11-30 1.72
2024-10-15 2024-11-25 0.6
2024-10-01 2024-10-14 1.16

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Fitoterapijos centras, MB (code 133385743) is a Lithuanian small partnership operating in wholesale of other food products. In the latest financial year, 2025, revenue amounted to EUR 72.1K and net profit reached EUR 18.1K, corresponding to a profit margin of 25.1%. Performance remained profitable, but both turnover and earnings declined over the last three years: revenue fell from EUR 92.8K in 2023 to EUR 80.6K in 2024 and then to EUR 72.1K in 2025, while net profit decreased from EUR 34.5K to EUR 22.7K and then to EUR 18.1K. The 2025 balance sheet shows total assets of EUR 171.9K, equity of EUR 169.7K and liabilities of EUR 2.3K, indicating a very lightly leveraged structure. Short-term assets of EUR 171.7K accounted for nearly all assets, while long-term assets were EUR 190. Key ratios for 2025 show return on equity of 10.7%, return on assets of 10.5%, debt-to-equity of 0.01 and asset turnover of 0.42x.